141 related articles for article (PubMed ID: 28429008)
1. Anticancer effects of novel resveratrol analogues on human ovarian cancer cells.
Vergara D; De Domenico S; Tinelli A; Stanca E; Del Mercato LL; Giudetti AM; Simeone P; Guazzelli N; Lessi M; Manzini C; Santino A; Bellina F; Maffia M
Mol Biosyst; 2017 May; 13(6):1131-1141. PubMed ID: 28429008
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
4. Anti-metastatic potential of resveratrol and its metabolites by the inhibition of epithelial-mesenchymal transition, migration, and invasion of malignant cancer cells.
Kim CW; Hwang KA; Choi KC
Phytomedicine; 2016 Dec; 23(14):1787-1796. PubMed ID: 27912881
[TBL] [Abstract][Full Text] [Related]
5. A novel anti‑cancer effect of resveratrol: reversal of epithelial‑mesenchymal transition in prostate cancer cells.
Li J; Chong T; Wang Z; Chen H; Li H; Cao J; Zhang P; Li H
Mol Med Rep; 2014 Oct; 10(4):1717-24. PubMed ID: 25069516
[TBL] [Abstract][Full Text] [Related]
6. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z; Fang J; Xia C; Shi X; Jiang BH
Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
8. Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment.
Hu FW; Tsai LL; Yu CH; Chen PN; Chou MY; Yu CC
Mol Nutr Food Res; 2012 Aug; 56(8):1247-58. PubMed ID: 22692956
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy.
Ferraresi A; Phadngam S; Morani F; Galetto A; Alabiso O; Chiorino G; Isidoro C
Mol Carcinog; 2017 Mar; 56(3):1164-1181. PubMed ID: 27787915
[TBL] [Abstract][Full Text] [Related]
10. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol.
Yu YH; Chen HA; Chen PS; Cheng YJ; Hsu WH; Chang YW; Chen YH; Jan Y; Hsiao M; Chang TY; Liu YH; Jeng YM; Wu CH; Huang MT; Su YH; Hung MC; Chien MH; Chen CY; Kuo ML; Su JL
Oncogene; 2013 Jan; 32(4):431-43. PubMed ID: 22410781
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein.
Sun Y; Wang H; Liu M; Lin F; Hua J
Mol Med Rep; 2015 Mar; 11(3):1975-81. PubMed ID: 25384583
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
Kueck A; Opipari AW; Griffith KA; Tan L; Choi M; Huang J; Wahl H; Liu JR
Gynecol Oncol; 2007 Dec; 107(3):450-7. PubMed ID: 17825886
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol from red grapes - pedestrian polyphenol or useful anticancer agent?
Gescher AJ
Planta Med; 2008 Oct; 74(13):1651-5. PubMed ID: 18446674
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target.
Lee MH; Choi BY; Kundu JK; Shin YK; Na HK; Surh YJ
Cancer Res; 2009 Sep; 69(18):7449-58. PubMed ID: 19738051
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell lines.
Baribeau S; Chaudhry P; Parent S; Asselin É
PLoS One; 2014; 9(1):e86987. PubMed ID: 24466305
[TBL] [Abstract][Full Text] [Related]
17. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
18. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y
Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits transforming growth factor-β2-induced epithelial-to-mesenchymal transition in human retinal pigment epithelial cells by suppressing the Smad pathway.
Chen CL; Chen YH; Tai MC; Liang CM; Lu DW; Chen JT
Drug Des Devel Ther; 2017; 11():163-173. PubMed ID: 28138219
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells.
Azios NG; Dharmawardhane SF
Neoplasia; 2005 Feb; 7(2):128-40. PubMed ID: 15802018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
